The PrP genotype of sheep of the improved Valachian breed
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články
PubMed
12800515
DOI
10.1007/bf02930968
Knihovny.cz E-zdroje
- MeSH
- alely MeSH
- chov MeSH
- genetická predispozice k nemoci * MeSH
- genotyp MeSH
- nemoci ovcí genetika MeSH
- ovce MeSH
- polymerázová řetězová reakce MeSH
- polymorfismus délky restrikčních fragmentů MeSH
- polymorfismus genetický * MeSH
- priony klasifikace genetika MeSH
- scrapie genetika MeSH
- sekvence nukleotidů MeSH
- sekvenční analýza DNA MeSH
- zvířata MeSH
- Check Tag
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- zvířata MeSH
- Publikační typ
- časopisecké články MeSH
- Geografické názvy
- Slovenská republika MeSH
- Názvy látek
- priony MeSH
In a worldwide majority of sheep breeds an excessive susceptibility to scrapie associated with the PrP gene alleles coding for valine (V; at the 136 codon) and glutamine (Q; at the 171 codon) (e.g., VRQ/VRQ, VRQ/ARQ, or ARQ/ARQ) was demonstrated. Particularly the PrPVRQ allele is closely associated with the high-risk development of the disease; the PrPARQ allele can also fulfill this function but under certain limited conditions. Polymorphism in the PrP gene sequences (conclusively related to the increased susceptibility of sheep to scrapie) of improved Valachian sheep from two Slovak regions, Orava and Spis, was determined. Examination of 735 sheep showed that ARR/ARQ was the most frequent genotype (45.2%). High-risk genotypes were determined in 32.4% of sheep (ARQ/ARQ 19.3, ARR/VRQ 9.0, ARR/VRQ 3.5, VRQ/VRQ 0.3, ARR/VRR 0.3). Low-risk genotypes were found in 67.7% of sheep (ARR/ARQ 45.2, ARR/ARR 10.9, ARR/AHQ 5.7, ARQ/ARQ 4.9, AHQ/AHQ 0.7, ARR/AHR 0.3). Despite the geographically distant flocks of improved Valachian sheep investigated no difference in the occurrence of individual PrP genotypes was observed.
Zobrazit více v PubMed
Eur J Epidemiol. 1991 Sep;7(5):520-3 PubMed
J Gen Virol. 1999 Sep;80 ( Pt 9):2527-34 PubMed
J Infect Dis. 1998 Oct;178(4):949-53 PubMed
APMIS. 2002 Jan;110(1):33-43 PubMed
Arch Virol. 1999;144(3):431-45 PubMed
Proc Natl Acad Sci U S A. 1997 May 13;94(10):4931-6 PubMed
J Comp Pathol. 2002 Jan;126(1):17-29 PubMed
J Gen Virol. 1993 Jun;74 ( Pt 6):1025-31 PubMed
Arch Virol. 1999;144(4):829-34 PubMed
Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13363-83 PubMed
EMBO J. 1985 Sep;4(9):2309-12 PubMed
J Gen Virol. 1994 May;75 ( Pt 5):989-95 PubMed
Vet Rec. 1998 Jun 6;142(23):623-5 PubMed
J Gen Virol. 1991 Oct;72 ( Pt 10):2411-7 PubMed
Genes Dev. 1994 Apr 15;8(8):959-69 PubMed
Folia Microbiol (Praha). 2000;45(6):475-83 PubMed
Vet Rec. 2000 Mar 18;146(12):335-8 PubMed
J Gen Virol. 1996 Oct;77 ( Pt 10):2669-73 PubMed
Nature. 1997 Mar 13;386(6621):137 PubMed
J Gen Virol. 1995 Aug;76 ( Pt 8):2097-101 PubMed
J Gen Virol. 1999 Apr;80 ( Pt 4):1073-7 PubMed
Ciba Found Symp. 1988;135:63-83 PubMed
Mamm Genome. 1993;4(8):463-4 PubMed
Arch Virol. 2001 Oct;146(10):2029-37 PubMed
Science. 1982 Apr 9;216(4542):136-44 PubMed
J Gen Virol. 1998 Aug;79 ( Pt 8):2079-82 PubMed
J Gen Virol. 1995 Oct;76 ( Pt 10):2577-81 PubMed
J Gen Virol. 1995 Mar;76 ( Pt 3):509-17 PubMed